CiteFacts · FDA Drug Shortages · FDA source
Cefotaxime Sodium Powder, for Solution
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 0143-9931-25) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 10 g (NDC 0143-9935-01) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 0143-9933-25) | Unavailable | 08/13/2026 |
| Hikma Pharmaceuticals USA, Inc. | Cefotaxime Sodium, Powder, for Solution, 500 mg (NDC 0143-9930-10) | Unavailable | 08/13/2026 |
| SteriMax, Inc. | Cefotaxime Sodium, Powder, for Solution, 1 g (NDC 21586-011-02) | Available | 06/15/2026 |
| SteriMax, Inc. | Cefotaxime Sodium, Powder, for Solution, 2 g (NDC 21586-012-02) | Available | 06/15/2026 |
Source facts
Grouped generic ingredient: Cefotaxime Sodium Powder, for Solution · 6 package records · Latest FDA row update: 08/13/2026
Therapeutic categories: Anti-Infective, Pediatric
Dosage forms: Powder, For Solution
Routes: INTRAMUSCULAR, INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.